KLK3 and prostate carcinoma: Future research should assess whether genetically adjusted PSA levels improve prediction of prostate cancer mortality and investigate PSA-related biomarkers, such as the ratio of free to total PSA and pro-PSA (a precursor PSA isoform), which may have higher specificity for prostate cancer detection58,59.